Lorundrostat, a selective aldosterone synthase inhibitor, significantly reduced 24-hour systolic blood pressure in individuals with uncontrolled and treatment-resistant hypertension, according to ...

Nevada Heart & Vascular Center in Las Vegas recently treated the first patient in Nevada to undergo an innovative new ...

For patients with uncontrolled and treatment-resistant hypertension, lorundrostat is associated with greater reductions in ...

Many runners have experienced what can happen when they are deep in training–perhaps performing at their peak–only to contract an upper respiratory infection or suffer a serious injury requiring ...

USA: A recent clinical trial has shown that Lorundrostat, a novel aldosterone synthase inhibitor, significantly lowers blood ...

The novel aldosterone inhibitor works, but longer-term safety data are needed before the drug might be approved.

Reducing hypertension significantly lowers the risk of dementia and cognitive impairment, a randomised controlled study has ...

“Several randomized controlled trials have examined the effect of antihypertensive medications versus placebo on dementia ...

Researchers at the University of California San Diego School of Medicine have identified a potential new treatment, an ...

Mineralys plans to provide additional data from the pivotal Phase 3 Launch-HTN at an upcoming medical conference and in a peer-reviewed publication. Additionally, the ongoing Transform-HTN open-label ...

New research provides further evidence that getting uncontrolled high blood pressure under control could be one way to reduce ...

Researchers in a new Chinese study discovered that “intensive blood pressure control" resulted in a 15% reduced dementia risk ...